US 11851690
Systems and methods for the treatment of hemoglobinopathies
granted A61KA61K31/7105A61K38/465
Quick answer
US patent 11851690 (Systems and methods for the treatment of hemoglobinopathies) held by Editas Medicine, Inc. expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Editas Medicine, Inc.
- Grant date
- Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/7105, A61K38/465